Higher Drug Costs, Less Choice: How PBMs Affect Everyday Americans’ Healthcare
LIPA News and Updates
Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
CVS Made a Big Bet on Privatized Medicare. It Looks Like a Flop.
The PBM-Insurer Mafia Comes for Community Pharmacies
Independent Pharmacies Continue to Face Financial Hardships as the Clock Ticks on PBM Reform
Pharmacies face prescription delays amid cyberattack
Pharmacy orgs urge Congress to finish bipartisan work on PBM reforms in Medicare, Medicaid
Blue Cross shelves plans to sell to Elevance for a second time; regulatory hearings canceled
There's a big gap in a new plan to speed up health insurance authorizations
Unlikely political allies take on drugmakers’ patent tactics
More than 13 million people lost Medicaid coverage this year, with Texas an epicenter of the 'unwinding'
Medicare urges payers to keep cash flowing to pharmacies
Opinion The U.S. pharmacy industry is crumbling. Here’s how to fix it.
Biden's limit on drug industry middlemen backfires, pharmacists say
"Pharmageddon" employee walkout adds to Walgreens woes
Some pharmacy staff from Walgreens, other chains are walking out again—here’s what you need to know
Express Scripts conspired to overcharge pharmacies, class action says
Payback Time! Community Pharmacists Cheer Class Action Lawsuit Against PBMs to Recoup DIR Fees
New coalition of Transparent PBM companies seeks to fix nation’s broken drug pricing system